Neoplasia/BPH

	Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial. Eur Urol Kitamura H, Tsukamoto T, Kakehi Y, Mizusawa J, Shibata T, Sasaki K, Tanikawa T, Hashine K, Fujimoto K, Masumori N, Kobayashi T, Habuchi T, Kimura T, Sugimoto M, Takahashi A, Adachi H, Matsui Y, Hatakeyama S, Ito A, Eto M, Nishiyama H, Urologic Oncology Study Group of the Japan Clinical Oncology Group. PMID: 41571573 [PubMed - as supplied by publisher]
	Natural product-mediated autophagy targeting for prostate cancer: A novel potential therapeutic strategy. Phytomedicine Zhang M, Zhong J, Yu M, Wang J, Zhang T, Liu M, Zhang P. PMID: 41571467 [PubMed - as supplied by publisher]
	[Therapy-Associated Neuroendocrine Prostate Cancer (tNEPC): A Diagnostic and Therapeutic Challenge in Uro-Oncology with Emerging Clinical Implications]. Aktuelle Urol von Amsberg G, Hartmann A, Eckstein M, Heidegger I. PMID: 41571001 [PubMed - as supplied by publisher]
	Assessing digital rectal examination and prostate-specific antigen knowledge: a study of Syrian medical students' knowledge for prostate cancer screening. BMC Med Educ Al-Shafie M, Al-Bitar A, Jouby M, Hiba I, Tello MK, Saifo M. PMID: 41572262 [PubMed - as supplied by publisher]
	ReIMAGINE study insights: Can abbreviated bpMRI transform prostate cancer screening? Eur Radiol Muglia VF, Verma S. PMID: 41572046 [PubMed - as supplied by publisher]
	Contemporary management of locally advanced prostate cancer: a narrative review and expert perspective. World J Urol Kafka M, Heidegger I. PMID: 41572035 [PubMed - in process]
	Cyclin D1 and the resistance landscape of HIF2 inhibition in clear-cell renal cell carcinoma: Insights from a mini-review. Biochem Biophys Res Commun Zhong Z, Yang A, Wang J, Tian Y, Ma B, Liu X. PMID: 41570697 [PubMed - as supplied by publisher]
	Evaluation of Loss of the Y Chromosome in Peripheral Blood as a Biomarker for Prostate Cancer. Prostate Lu J, Lu Y, Kobayashi T, Hachiya T, Wakita H, Jin Y, Tanaka Y, Ikehata Y, Nagata M, Ide H, Horie S. PMID: 41570183 [PubMed - as supplied by publisher]
	Effect of Celecoxib Combined With Low-Dose-Rate Brachytherapy on Long-Term Oncological Outcomes and Quality of Life in Prostate Cancer: Post Hoc Analysis of an Open-Label Controlled Randomized Trial. Prostate Nakai Y, Onishi K, Asakawa I, Miyake M, Yamaki K, Isohashi F, Fujimoto K, Tanaka N. PMID: 41570179 [PubMed - as supplied by publisher]
	Pelvic Lymph Node Staging With PSMA PET in Prostate Cancer: Surgical Validation With Implications for Radiotherapy Planning. Prostate Ozen A, Sarikaya Z, Gur C, Ozboru D, Canat HL. PMID: 41570172 [PubMed - as supplied by publisher]
	Development and Validation of a Nomogram for Predicting Pathological Upgrading in Men With Biopsy Gleason 3 + 3 Prostate Cancer Undergoing Radical Prostatectomy: A Population-Based Study. Prostate Li H, Xiong S, Wang M, Liu M, Wang J, Wang J, Lv Z. PMID: 41570160 [PubMed - as supplied by publisher]
	Productivity losses and treatment cost of benign prostatic hyperplasia in Ghana. PLoS One Dadee-Seshie DS, Agbeteti SG, Kpankyaano B, Adamu AF, Adanu SK, Alhassan Y, Dalaba MA, Adanu KK. PMID: 41570021 [PubMed - indexed for MEDLINE]
	Core Stability in Women With and Without Lower Urinary Tract Symptoms: The CORE-LUTS Study. Int Urogynecol J Bennis S, Kumar A, Chatwin HV, Acevedo-Alvarez M, Choi H, Wesolowski M, Fitzgerald CM. PMID: 41569411 [PubMed - as supplied by publisher]
	First-in-class HIF-2α therapy in genitourinary oncology: Belzutifan from von Hippel-Lindau disease to advanced renal cell carcinoma. Cancer Chemother Pharmacol Karaman I, Erdem D, Cetin B. PMID: 41569310 [PubMed - indexed for MEDLINE]
	NF-κB (p65, p50), IL-18, and IL-10 as Therapeutic Targets in Prostate Cancer and BPH: Molecular Insights into Inflammation-Driven Pathogenesis. Asian Pac J Cancer Prev Dwivedi S, Saini S, - A, Np AK, Bansal A, Sharma RS, Shekhar S, - D, Goel A, Khattri S. PMID: 41569207 [PubMed - indexed for MEDLINE]
	The Radical Prostatectomy Versus Brachytherapy for the Management of Low- and Intermediate-Risk Prostate Cancer: A Meta-Analysis of Observational Studies Focusing on Oncological Outcomes. Asian Pac J Cancer Prev Warli SM, Ikram MF, Kadar DD, Siregar GP, Prapiska FF, Laksmi LI, Tala ZZ, Siregar DI, Siregar MIS. PMID: 41569192 [PubMed - indexed for MEDLINE]
	Tumor Morphology as a Risk Factor for Muscle Invasiveness in Newly Diagnosed Bladder Cancer: A Stratified Analysis. Asian Pac J Cancer Prev Do NT, Nguyen Tung L, Nguyen Cong D, Do MT. PMID: 41569182 [PubMed - indexed for MEDLINE]
	First look at evaluation of serum angiopoietin-like 4 levels in bladder cancer: A pilot study. J Physiol Pharmacol Strojny Z, Kanikowska A, Sikora W, Lewandowska M, Sato M, Strojny M, Zuraszek-Szymanska J, Deja T, Paszynska E, Korybalska K, Breborowicz A, Witowski J, Kanikowska D. PMID: 41569057 [PubMed - indexed for MEDLINE]
	Coriandrum sativum improves prognosis in clear cell renal cell carcinoma by targeting NEK6 to modulate the immune microenvironment: a predictive study based on network pharmacology and multi-omics analysis. Artif Cells Nanomed Biotechnol Li J, Zhang Y, Wang X, Zhang P, Xu Z, Huang R, Hu H. PMID: 41568676 [PubMed - indexed for MEDLINE]
	Identification of a Cuproptosis-Related Molecular Signature for Predicting Biochemical Recurrence in Prostate Cancer. Comb Chem High Throughput Screen Chen DN, Wu XH, You Q, Zhuang RB, Ruan ZT, Zhu JM, Zheng QS, Chen YH, Wei Y, Lin XD, Xue XY. PMID: 41568495 [PubMed - as supplied by publisher]

Articles 1 - 20 / 184824

Page 1 of 9242



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy